• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利米兰内科病房第一波和第二波 COVID-19 之间的比较:一项回顾性观察研究。

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.

机构信息

Division of Internal Medicine, Immunology and Allergology, Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy.

出版信息

Intern Emerg Med. 2022 Nov;17(8):2219-2228. doi: 10.1007/s11739-022-03052-3. Epub 2022 Aug 15.

DOI:10.1007/s11739-022-03052-3
PMID:35970982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9377666/
Abstract

COVID-19 spread in two pandemic waves in Italy between 2020 and 2021. The aim of this study is to compare the first with the second COVID-19 wave, analyzing modifiable and non-modifiable factors and how these factors affected mortality in patients hospitalized in Internal Medicine wards. Consecutive patients with SARS-CoV-2 infection and dyspnea requiring O supplementation were included. The severity of lung involvement was categorized according to the patients' oxygen need. Six hundred and ten SARS-CoV-2 hospitalized patients satisfied the inclusion criteria. The overall estimated 4-week mortality was similar in the two pandemic waves. Several variables were associated with mortality after univariate analysis, but they lacked the significance after multivariable adjustment. Steroids did not exert any protective effect when analyzed in time-dependent models in the whole sample; however, steroids seemed to exert a protective effect in more severe patients. When analyzing the progression to different states of O supplementation during hospital stay, mortality was almost exclusively associated with the use of high-flow O or CPAP. The analysis of the transition from one state to the other by Cox-Markov models confirmed that age and the severity of lung involvement at admission, along with fever, were relevant factor for mortality or progression.

摘要

2020 年至 2021 年,意大利的 COVID-19 在两波大流行中传播。本研究的目的是比较 COVID-19 的第一波和第二波,分析可改变和不可改变的因素,以及这些因素如何影响在综合内科病房住院的患者的死亡率。纳入了因 SARS-CoV-2 感染和呼吸困难需要补充氧气的连续患者。根据患者的氧气需求,将肺受累的严重程度进行分类。610 名 SARS-CoV-2 住院患者符合纳入标准。在两波大流行中,总体估计的 4 周死亡率相似。在单变量分析中,有几个变量与死亡率相关,但在多变量调整后缺乏意义。在整个样本中,在时间依赖性模型中分析时,类固醇没有发挥任何保护作用;然而,类固醇在更严重的患者中似乎发挥了保护作用。在分析住院期间不同供氧状态的进展时,死亡率几乎完全与使用高流量氧或 CPAP 相关。Cox-Markov 模型分析从一种状态到另一种状态的转变证实,年龄和入院时的肺部受累严重程度,以及发热,是死亡率或进展的相关因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ee/9377666/30edd495693a/11739_2022_3052_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ee/9377666/33506f2e34eb/11739_2022_3052_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ee/9377666/30edd495693a/11739_2022_3052_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ee/9377666/33506f2e34eb/11739_2022_3052_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ee/9377666/30edd495693a/11739_2022_3052_Fig2_HTML.jpg

相似文献

1
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.意大利米兰内科病房第一波和第二波 COVID-19 之间的比较:一项回顾性观察研究。
Intern Emerg Med. 2022 Nov;17(8):2219-2228. doi: 10.1007/s11739-022-03052-3. Epub 2022 Aug 15.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Impact of COVID-19 pandemic waves on changes in surgical urgency volumes and severity in the regional hospital network of Trento (Northern Italy): a descriptive epidemiological analysis.COVID-19 大流行浪潮对特伦托(意大利北部)区域医院网络中手术紧迫性和严重程度变化的影响:描述性流行病学分析。
Epidemiol Prev. 2021 Nov-Dec;45(6):470-476. doi: 10.19191/EP21.6.131.
4
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study.意大利南部发生的三波 COVID-19 的临床特征:一项多中心队列研究的结果。
Int J Environ Res Public Health. 2022 Nov 30;19(23):16003. doi: 10.3390/ijerph192316003.
5
Long-Term Survival among Patients Hospitalized for COVID-19 during the First Three Epidemic Waves: An Observational Study in a Northern Italy Hospital.COVID-19 患者在三个流行波次期间住院的长期生存情况:意大利北部一家医院的观察性研究。
Int J Environ Res Public Health. 2022 Nov 19;19(22):15298. doi: 10.3390/ijerph192215298.
6
Epidemiology, Clinical Profile, Intensive Care Needs and Outcome in Children with SARS-CoV-2 Infection Admitted to a Tertiary Hospital During the First and Second Waves of the COVID-19 Pandemic in India.印度 COVID-19 大流行第一波和第二波期间,收治于一家三级医院的 SARS-CoV-2 感染患儿的流行病学、临床特征、重症监护需求和结局。
Indian J Pediatr. 2023 Feb;90(2):131-138. doi: 10.1007/s12098-022-04283-0. Epub 2022 Aug 3.
7
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
8
The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy.意大利北部、中部和南部前两波 SARS-CoV-2 大流行的三个方面。
J Infect Public Health. 2023 Apr;16(4):520-525. doi: 10.1016/j.jiph.2023.02.002. Epub 2023 Feb 7.
9
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
10
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.轻症肺炎患者无需住院的情况下使用类固醇进行 COVID-19 门诊治疗作为改变疾病进程的机会:一项随机对照试验的结构化总结。
Trials. 2020 Jul 9;21(1):632. doi: 10.1186/s13063-020-04575-w.

引用本文的文献

1
Unraveling relevant cross-waves pattern drifts in patient-hospital risk factors among hospitalized COVID-19 patients using explainable machine learning methods.使用可解释机器学习方法揭示住院COVID-19患者中患者-医院风险因素的相关交叉波模式漂移。
BMC Infect Dis. 2025 Apr 15;25(1):537. doi: 10.1186/s12879-025-10766-0.
2
COVID-19 in three waves in a tertiary referral hospital in Belgium: a comparison of patient characteristics, management, and outcome.比利时一家三级转诊医院的三波 COVID-19:患者特征、治疗和结局比较。
Virol J. 2024 May 30;21(1):119. doi: 10.1186/s12985-024-02360-8.
3
Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study.

本文引用的文献

1
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.奥密克戎对抗体中和作用的逃逸显著。
Nature. 2022 Feb;602(7898):671-675. doi: 10.1038/s41586-021-04389-z. Epub 2021 Dec 23.
2
Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020.2020 年 COVID-19 大流行期间意大利的超额死亡率:评估第一波和第二波之间的差异
Front Public Health. 2021 Jul 16;9:669209. doi: 10.3389/fpubh.2021.669209. eCollection 2021.
3
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).
分析和临床决定因素在伦巴第地区的 COVID-19 后综合征:来自纵向队列研究的证据。
BMJ Open. 2024 Feb 6;14(2):e075185. doi: 10.1136/bmjopen-2023-075185.
4
A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications.一篇图文并茂的文章,描述了新冠疫情期间新冠肺炎病例的CT成像特征,特别关注肺部表现和肺外血管腹部并发症。
Biomedicines. 2023 Jul 26;11(8):2113. doi: 10.3390/biomedicines11082113.
5
Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy.意大利伦巴第大区两年的 SARS-CoV-2 大流行和 COVID-19 疫情。
Intern Emerg Med. 2023 Aug;18(5):1445-1451. doi: 10.1007/s11739-023-03315-7. Epub 2023 Jun 14.
6
The role of immune activation and antigen persistence in acute and long COVID.免疫激活和抗原持续存在在急性和长新冠中的作用。
J Investig Med. 2023 Jun;71(5):545-562. doi: 10.1177/10815589231158041. Epub 2023 Mar 6.
7
Clinical Characteristics and Outcomes of Patients with Acute Respiratory Failure Due to SARS-CoV-2 Interstitial Pneumonia Treated with CPAP in a Medical Intermediate Care Setting: A Retrospective Observational Study on Comparison of Four Waves.在医疗中级护理环境中接受持续气道正压通气(CPAP)治疗的新型冠状病毒肺炎(SARS-CoV-2)间质性肺炎所致急性呼吸衰竭患者的临床特征及结局:四波比较的回顾性观察研究
J Clin Med. 2023 Feb 16;12(4):1562. doi: 10.3390/jcm12041562.
8
Insights from comparison of the clinical presentation and outcomes of patients hospitalized with COVID-19 in an Italian internal medicine ward during first and third wave.意大利内科病房中首批和第三波新冠病毒病住院患者临床表现及预后比较的见解
Front Med (Lausanne). 2023 Feb 1;10:1112728. doi: 10.3389/fmed.2023.1112728. eCollection 2023.
9
Long-Term Survival among Patients Hospitalized for COVID-19 during the First Three Epidemic Waves: An Observational Study in a Northern Italy Hospital.COVID-19 患者在三个流行波次期间住院的长期生存情况:意大利北部一家医院的观察性研究。
Int J Environ Res Public Health. 2022 Nov 19;19(22):15298. doi: 10.3390/ijerph192215298.
成人新型冠状病毒肺炎患者在非重症监护病房的临床管理:来自意大利抗感染治疗学会(SITA)和意大利肺病学会(SIP)的指南
Infect Dis Ther. 2021 Dec;10(4):1837-1885. doi: 10.1007/s40121-021-00487-7. Epub 2021 Jul 30.
4
Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.瑞德西韦治疗 SARS-CoV-2 引起的 COVID-19 的疗效和安全性:系统评价和荟萃分析。
BMJ Open. 2021 Jun 24;11(6):e048416. doi: 10.1136/bmjopen-2020-048416.
5
Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.瑞德西韦治疗 COVID-19 的安全性和疗效:系统评价和荟萃分析。
J Pharm Pharm Sci. 2021;24:237-245. doi: 10.18433/jpps31870.
6
What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review.在急性医院护理中,经过验证的衰弱评分与 COVID-19 成年患者的死亡率之间存在什么关系?系统评价。
Age Ageing. 2021 May 5;50(3):608-616. doi: 10.1093/ageing/afab008.
7
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials.甲泼尼龙是否降低住院 COVID-19 患者的死亡风险?一项随机对照试验的荟萃分析。
Expert Rev Respir Med. 2021 Aug;15(8):1049-1055. doi: 10.1080/17476348.2021.1925546. Epub 2021 Jul 2.
8
Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom.新冠肺炎住院患者使用地塞米松:是否使用、何时使用以及用于何人。
J Clin Med. 2021 Apr 10;10(8):1607. doi: 10.3390/jcm10081607.
9
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI).意大利内科学会(SIMI)的 SIMI-COVID-19 研究对意大利内科病房管理的 3044 例 COVID-19 患者的死亡相关临床因素进行了分析。
Intern Emerg Med. 2021 Jun;16(4):1005-1015. doi: 10.1007/s11739-021-02742-8. Epub 2021 Apr 24.
10
Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation.COVID-19 患者在无需通气情况下使用低分子肝素、输血与死亡率。
J Thromb Thrombolysis. 2021 Oct;52(3):772-778. doi: 10.1007/s11239-021-02429-z. Epub 2021 Apr 12.